D-Altrononitrile, 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-, 6-(2-methylpropanoate)
- Product Name
- D-Altrononitrile, 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-, 6-(2-methylpropanoate)
- CAS No.
- 2647441-36-7
- Chemical Name
- D-Altrononitrile, 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-, 6-(2-methylpropanoate)
- Synonyms
- Obeldesivir;SHEN26;SHEN26, 10 mM in DMSO;D-Altrononitrile, 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-, 6-(2-methylpropanoate);5-ethenyl-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione;((2R,3S,4R,5R)-5-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methyl isobutyrate;RNA,SHEN26,viral load,ATV 006,ATV006,antiviral,SARS coronavirus,Vero E6 cells,podrugs,Inhibitor,ATV-006,SARS-CoV,inhibit
- CBNumber
- CB810690992
- Molecular Formula
- C16H19N5O5
- Formula Weight
- 361.36
- MOL File
- 2647441-36-7.mol
D-Altrononitrile, 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-, 6-(2-methylpropanoate) Property
- Density
- 1.59±0.1 g/cm3(Predicted)
- storage temp.
- 4°C, protect from light
- solubility
- DMSO : 250 mg/mL (691.85 mM; Need ultrasonic)
- form
- Solid
- pka
- 12.00±0.70(Predicted)
- color
- White to off-white
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
- Precautionary statements
-
P264Wash hands thoroughly after handling.
P264Wash skin thouroughly after handling.
P270Do not eat, drink or smoke when using this product.
P280Wear protective gloves/protective clothing/eye protection/face protection.
P302+P352IF ON SKIN: wash with plenty of soap and water.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
P332+P313IF SKIN irritation occurs: Get medical advice/attention.
P337+P313IF eye irritation persists: Get medical advice/attention.
P501Dispose of contents/container to..…
N-Bromosuccinimide Price
- Product number
- 40404
- Product name
- Obeldesivir
- Purity
- ≥98%
- Packaging
- 1mg
- Price
- $72
- Updated
- 2026/04/30
- Product number
- 40404
- Product name
- Obeldesivir
- Purity
- ≥98%
- Packaging
- 5mg
- Price
- $323
- Updated
- 2026/04/30
- Product number
- 40404
- Product name
- Obeldesivir
- Purity
- ≥98%
- Packaging
- 10mg
- Price
- $501
- Updated
- 2026/04/30
- Product number
- 40404
- Product name
- Obeldesivir
- Purity
- ≥98%
- Packaging
- 25mg
- Price
- $895
- Updated
- 2026/04/30
- Product number
- 302161
- Product name
- ((2R,3S,4R,5R)-5-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methyl isobutyrate
- Packaging
- 50.00mg
- Price
- $76
- Updated
- 2026/05/19
D-Altrononitrile, 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-, 6-(2-methylpropanoate) Chemical Properties,Usage,Production
Uses
Obeldesivir (ATV006) is a potent, orally active antiviral agent and ester proagents of GS-441524. Obeldesivir inhibits the replication of SARS-CoV-2 and its variants. Obeldesivir can be used for SARS-CoV-2 research[1].
in vivo
Obeldesivir (5-25 mg/kg; p.o. and i.v.; Sprague Dawley rats) has favorable pharmacokinetic profiles in rats with high oral bioavailability (F %) of 81.5% and maximum blood concentration (Cmax) of 8.2 μM[1].
Obeldesivir (250-500 mg/kg; p.o.; daily, for 4 days; hACE2 knock-in and Ad5-hACE2 mice) has antiviral activity and inhibits SARS-CoV-2 replication in mouse models[1].
Obeldesivir (100-250 mg/kg; p.o.; daily, for 10 days) reduces lung damage and protects K18-hACE2 mice[1].
Obeldesivir (10-150 mg/kg; p.o.; daily, for 3 days) reduces virus titers and lung damage caused by Delta variant infection in K18-hACE2 mice[1].
| Animal Model: | Sprague Dawley rats[1] | ||||||||||||||||||
| Dosage: | 5 and 25 mg/kg | ||||||||||||||||||
| Administration: | Oral administration (25 mg/kg) and intravenous injection (5 mg/kg) | ||||||||||||||||||
| Result: | 1.19
|
| Animal Model: | hACE2 knock-in and Ad5-hACE2 mice[1] |
| Dosage: | 250 and 500 mg/kg |
| Administration: | Oral administration; daily, for 4 days |
| Result: | Inhibited gRNA and sgRNA, which is Biomarkers of coronavirus replication. Reduced the viral load and pathological damage of the lung. |
| Animal Model: | K18-hACE2 mice[1] |
| Dosage: | 100 and 250 mg/kg |
| Administration: | Oral administration; daily, for 10 days |
| Result: | Reduced viral RNA and increased the survival rate of mice. Reduced evidence of lung pathology and the production of inflammatory cytokines and chemokines in the lung tissues. |
| Animal Model: | K18-hACE2 mice[1] |
| Dosage: | 10, 30, 80 and 150 mg/kg |
| Administration: | Oral administration; daily, for 3 days |
| Result: | Reduced viral load in a dose-dependent manner and alleviated the symptoms in the lung. |
References
[1] Cao L, et, al. The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants. Sci Transl Med. 2022 May 17:eabm7621. DOI:10.1126/scitranslmed.abm7621
D-Altrononitrile, 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-, 6-(2-methylpropanoate) Preparation Products And Raw materials
Raw materials
Preparation Products
D-Altrononitrile, 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-, 6-(2-methylpropanoate) Suppliers
- Tel
- 021-38681880 13817889927
- Fax
- 0213390-8196
- sales@synmedia-chem.com
- Country
- China
- ProdList
- 249
- Advantage
- 58
- Tel
- 021-52996696,15000506266 15000506266
- Fax
- +86-21-52996696
- Country
- China
- ProdList
- 4845
- Advantage
- 55
- Tel
- 021-65675885 18964387627
- Fax
- 021-65675885
- info@efebio.com
- Country
- China
- ProdList
- 9803
- Advantage
- 58
- Tel
- 021-31433387 15618786686
- Fax
- QQ:1369748377
- sales@rechemscience.com
- Country
- China
- ProdList
- 2970
- Advantage
- 58
- Tel
- 0512-65816829 18662214788
- Fax
- 0512-65816829
- info@rovathin.com.cn
- Country
- China
- ProdList
- 9978
- Advantage
- 58
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32466
- Advantage
- 58
- Tel
- 63313187 15358055255
- Fax
- QQ:63313187
- 63313187@qq.com
- Country
- China
- ProdList
- 1983
- Advantage
- 58
- Tel
- 18051384581
- sales@chemhifuture.com
- Country
- China
- ProdList
- 2987
- Advantage
- 58
- Tel
- 400-1647117 13681763483
- product02@bidepharm.com
- Country
- China
- ProdList
- 59936
- Advantage
- 58
- Tel
- 4008200310 15002144251
- marketing@tsbiochem.com
- Country
- China
- ProdList
- 24955
- Advantage
- 58